Formulation of a modified-release pregabalin tablet using hot-melt coating with glyceryl behenate

详细信息    查看全文

• 作者：Kyu Ho Jeong^c ; ¹ ; Hye Seung Woo^c ; ¹ ; Chae Jin Kim^c ; Kyung Hwa Lee^c ; Jun Young Jeon^a ; Sang Young Lee^a ; Jae-Hoon Kang^a ; Sangkil Lee^b ; Young Wook Choi^c ; ^{ywchoi@cau.ac.kr" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Pregabalin ; Glyceryl behenate ; Hot-melt coating ; Drug release ; Pharmacokinetic ; Stability
• 刊名：International Journal of Pharmaceutics
• 出版年：2015
• 出版时间：10 November 2015
• 年：2015
• 卷：495
• 期：1
• 页码：1-8
• 全文大小：1182 K

文摘

A modified-release (MR) tablet of the anti-anxiety drug pregabalin (PRE) was prepared by hot-melt coating PRE with glyceryl behenate (GB) as a release retardant and compressing to form a matrix with microcrystalline cellulose (MCC) as a hydrophilic diluent. GB-coated PRE had a size in the range of 177–290 渭m with good to acceptable flowability. Tablet hardness decreased slightly as GB content increased. PRE release from the tablet matrices was successfully modified by altering the ratio of MCC and GB, and it was found that dissolution- or diffusion-controlled release depended on the amount of GB used. Drug release was pH-independent. An accelerated stability test on the most promising MR tablet at 40 °C and 75% relative humidity for 6 months showed no significant changes in PRE content, and the occurrence of total impurities—including PRE-lactam—was within acceptable limits. After oral administration of the selected MR tablet or a commercial IR capsule (Lyrica) to healthy human volunteers, pharmacokinetic parameters including T_max, C_max, AUC_0–24, and T_1/2 were compared. The confidence interval of AUC_0–24 was within the adequate range, but that of C_max was inadequate. This study demonstrated the potential use of GB for PRE-containing MR formulations.